Protak trials with Public Health England in 2015

 In Blog Posts

As part of the continual commitment to further research on Enzyme Indicators, Protak have commissioned Public Health England to further study tAK Enzyme Indicators. Over the next 12 months Protak and PHE will be working with select pharmaceutical partners to introduce the revolutionary Enzyme Indicators. The trial partners will gain huge and invaluable insight into exactly what advances this key technology brings. Not only will the trial partners benefit from insider knowledge, the EI trial partners will be guaranteed first and initially exclusive access to our complete data centres. If you would like more information on the trial then please contact us.

About Protak Scientific

I am passionate about making the world a better and safer place hence my focus on bringing the revolutionary Enzyme Indicator technology to the pharmaceutical and medical markets - a way to know decontamination results in seconds, not days. With over 16 years experience in technical, pharmaceutical and scientific sectors, I have a diverse leadership background. I have gained significant experience in, and insight into, pharmaceutical and biotech fields through roles such as Sales Director, Managing Director and CEO, in companies such as Monmouth Scientific, Howorth Air Technology, WH Leary and now Protak Scientific.

View All Posts
Recent Posts
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.